Review Article

Cardiac Implications of COVID-19 in Deceased and Recovered Patients: A Systematic Review

Table 3

Symptoms of the patients at the time of presentation.

FeverCoughDyspnoeaMyalgiaHeadacheDiarrhoea

AuthorTotalTotalTotalTotalTotalTotal
SurvivorSurvivorSurvivorSurvivorSurvivorSurvivor
NonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivor
value value value value value value

Wang et al. [12]104 (97.2)67 (62.6)35 (32.7)33 (30.8)7 (6.5)7 (6.5)
85 (96.6)56 (63.6)20 (22.7)28 (31.8)7 (8.0)3 (3.4)
19 (100.0)11 (57.9)15 (78.9)5 (26.3)0 (0)4 (21.1)
10.639<0.0010.6380.3480.018

Yang et al. [13]51 (98%)40 (77%)33 (63·5%)6 (11·5%)3(6%)NA
20 (100%)15 (75%)12 (60%)2 (10%)1 (5%)
31 (97%)25 (78%)21 (66%)4 (12·5%)2 (6%)
NANANANANA

Zhou et al. [14]180 (94%)151 (79%)NA29 (15%)NA9 (5%)
129 (94%)112 (82%)21 (15%)7 (5%)
51 (94%)39 (72%)8 (15%)2 (4%)
0·940·150.930·67

Si et al. [15]NANANANANANA
41 (83.7)30 (61.2)15(30.6)12 (24.5)
101 (71.1)76 (62.8)62 (51.2)25 (20.7)
10.90.020.7

Shi et al. [16]NANANANANANA

Fang-fang Chen et al. [17]584 (85.9%)462 (67.8%)123 (18.1%)NANA119 (17.5%)
494 (85.8%)397 (68.8%)95 (16.5%)104 (18.1%)
90 (86.5%)65 (62.5%)28 (26.9%)15 (14.4%)
0.8350.2050.0110.366

Xie et al. [18]630 (85.9)550 (75)444 (60.7)NANA90 (12.3)
287 (84.7)254 (74.9)163 (48.1)44 (13)
343 (87.1)296(75.1)281 (71.3)46 (11.8)
0.3520.95<0.0010.592

Chen et al. [19]249 (91)185 (68)120 (44)60 (22)31 (11)77 (28)
145 (90)106 (66)50 (31)39 (24)20 (12)50 (31)
104 (92)79 (70)70 (62)21 (19)11 (10)27 (24)
NANANANANANA

Deng et al. [20]1898599571333
94 (81.0)38 (32.8)22 (19.0)27 (23.3)7 (6.0)14 (12.1)
95 (87.2)47 (43.1)77 (70.6)30 (27.5)6 (5.5)19 (17.4)
0.2110.109<0.0010.4640.8650.252

Wang et al. [21]209 (71.3%)150 (51.2%)81 (27.6%)17 (5.8%)10 (3.4%)19 (6.5%)
119 (67.2%)81 (45.8%)33 (18.6%)11 (6.2%)7 (4.0%)16 (9.0%)
90 (77.6%)69 (59.5%)48 (41.4%)6 (5.2%)3 (2.6%)3 (2.6%)
0.0550.022<0.0010.7090.5280.028

Amit et al. [9]NANANANANANA

Alamdari et al. [10]384 [83.7%]251 [54.7%]NA284 [61.9%]89 [19.4%]125 [27.2%]
326 [82.3%]213 [53.8%]247 [62.4%]78 [19.7%]105 [26.5%]
58 [92.1%]38 [60.3%]37 [58.7%]11 [17.5%]20 [31.7%]
0.0520.3440.580.6770.386

Stefano Ghio et al. [11]NANANANANANA
171 (62.2%)
93 (75.6%)
0.009

Yukun et al. [18]96 (95%)79 (78.2%)17 (16.8%)13 (12.9%)NA9 (8.9%)
62 (93.9%)53 (80.3%)8 (12.1%)8 (12.1%)6 (9.1%)
34 (97.1%)26 (74.3%)9 (25.7%)5 (14.3%)3 (8.6%)
0.6560.4860.0820.7571

NA= not applicable.